Positive news for new Cushing’s drug

September 23, 2019

In a press release, Strongbridge Biopharma announced comprehensive positive results of their Phase 3 SONICS study of RECORLEVTM (levoketoconazole) for the potential treatment of endogenous Cushing’s syndrome. The results were published online in The Lancet

A review of drugs for tumors that produce ACTH

July 16, 2019

In this podcast, Dr. Blevins reviews a study conducted at the Ludwig Maximilian University of Munich, Germany on pituitary tumor therapeutics and the treatment for tumors that produce ACTH and cause Cushing’s.  Dr. Blevins reviews